Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Trading Statement

7 Jan 2008 07:00

Tarsus Group PLC07 January 2008 7 January 2008 TARSUS GROUP PLC TRADING UPDATE Tarsus Group plc ('Tarsus' or 'the Group'), the international media group withinterests in exhibitions, conferences, publishing and online media hascontinued to trade well in the second half of 2007 with strong performances fromall of its key products. Group like-for-like organic revenue growth for theyear to 31 December 2007 has been 15% and, as a result, the Board expects fullyear 2007 results to be towards the top end of market expectations. Labelexpo Europe, the Group's second largest exhibition, produced revenue growth10% above that of the 2005 event and rebookings for 2009 are already at 90% ofthe total 2007 event. The three important French exhibitions Heavent (event marketing), IP Convergence (IT) and Educatec (education) were all well ahead of2006 and contributed to strong like-for-like organic revenue growth from theFrench division of 14% for the year as a whole. The final medical event of theyear, Anti-Ageing Las Vegas, was a great success with revenues and attendees up35% and 30% respectively over 2006. The development of our emerging markets portfolio was significantly acceleratedwith the November 2007 acquisition of Fairs & Exhibitions Limited, whose keyevent is the Dubai Air Show. This biennial show, which is now the Group's largest, was extremely well received with visitor numbers up nearly 30% from the2005 event to 45,000 and record customer orders in excess of US$100 billion.The event will move to a new purpose-built venue in 2009 which has resulted inrequests for large upgrades in space from major exhibitors. Other emerging market events were China-focused in the second half and our keyevent, the third edition of Labelexpo Asia in Shanghai, saw revenues rise by12% above the 2005 event and visitor numbers by 54%. Rebookings are strong and well ahead of the previous cycle. Caroo, our online business, has continued its strong momentum with like-for-likeorganic revenues up by 21% for the full year. We have appointed a newdivisional CEO in the US to drive growth in that market following theacquisition of the DMS Group in July. Outlook for 2008 The broadening of the Group's base is an important step in underpinning ourability to grow consistently in the years ahead. During 2007 we have continuedto expand the number of sectors served by the Group and made good progress in diversifying our revenues geographically. Average emerging market revenues forthe 2007/2008 cycle are expected to be approximately 16% of the total up from5% for the 2005/2006 cycle. The Group is strongly second half weighted and, with the major Labelexpo showreturning to the US from Europe in 2008, dollar exposure will be higher than in2007. Our significant events in the first quarter of 2008 - the US Off-Price show, the Mod'Amont clothing accessories event in Paris and GESS (a neweducational show in Dubai) - are developing extremely well. Overall, forwardbookings are strong and the Board remains confident that 2008 will be anotheryear of strong like-for-like growth for the Group. The Group expects to announce its preliminary results for the year to 31December 2007 on 3 March 2008. Ends For further information please contact: Tarsus Group plc: Douglas Emslie: Group Managing Director: Tel 020 8846 2700 Media: Matthew Moth :Madano Partnership: Tel: 020 7593 4000 Investors: Neville Harris : IRFocus: Tel: 020 7593 4215 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th Mar 20122:53 pmRNSAcquisition of Life Media
30th Mar 201211:53 amRNSTotal Voting Rights
28th Mar 20124:58 pmRNSHolding(s) in Company
27th Mar 20125:23 pmRNSHolding(s) in Company
27th Mar 20125:22 pmRNSDirector/PDMR Shareholding
26th Mar 20123:33 pmRNSHolding(s) in Company
23rd Mar 20124:25 pmRNSHolding(s) in Company
23rd Mar 20128:05 amRNSAdmission of Placing Shares
20th Mar 20127:00 amRNSAcquisition and Placing
7th Mar 20127:00 amRNSFinal Results
27th Feb 201210:00 amRNSChange of time for results presentation
31st Jan 20125:00 pmRNSTotal Voting Rights
27th Jan 20123:00 pmRNSNotice of Results
19th Jan 201212:00 pmRNSApplication for Admission
5th Jan 20127:00 amRNSTrading Update
20th Dec 20119:00 amRNSScrip Dividend Circular
5th Dec 201110:23 amRNSCompletion of Disposal
28th Nov 20111:09 pmRNSResult of EGM
17th Nov 20117:00 amRNSInterim Management Statement
9th Nov 20115:22 pmRNSBlocklisting Interim Review
7th Nov 20114:30 pmRNSDisposal of ModAmont SAS - posting of circular
3rd Oct 20117:00 amRNSTrading Statement
26th Aug 20117:00 amRNSInterim Financial Statements 2011
8th Aug 20112:56 pmRNSDirector/PDMR Shareholding
29th Jul 20115:48 pmRNSTotal Voting Rights
29th Jul 20114:07 pmRNSDirector/PDMR Shareholding
8th Jul 20111:39 pmRNSApplication for Admission
5th Jul 20114:52 pmRNSHolding(s) in Company
30th Jun 20114:00 pmRNSTotal Voting Rights
30th Jun 20117:00 amRNSPre-close Trading Statement
20th Jun 20115:36 pmRNSDirector/PDMR Shareholding
17th Jun 20112:17 pmRNSResult of AGM
9th Jun 20115:45 pmRNSScrip dividend circular
9th Jun 20115:44 pmRNSHolding(s) in Company
9th Jun 20115:41 pmRNSHolding(s) in Company
9th Jun 20115:39 pmRNSHolding(s) in Company
9th Jun 20115:37 pmRNSHolding(s) in Company
7th Jun 20118:05 amRNSAcquisition of IFO and Total Voting Rights
6th Jun 20113:49 pmRNSResult of EGM
1st Jun 20115:14 pmRNSApplication for Admission
24th May 20115:32 pmRNSHolding(s) in Company
20th May 20114:31 pmRNSAnnual Information Update
19th May 20117:00 amRNSPlacing and Acquisition
9th May 20115:00 pmRNSBlocklisting Interim Review
5th May 20117:00 amRNSDirectorate Change
5th May 20117:00 amRNSInterim Management Statement
4th May 20117:00 amRNSNotice of Interim Management Statement
28th Apr 20113:42 pmRNSTotal Voting Rights
19th Apr 20117:00 amRNSAnnual Report & Accounts
31st Mar 20113:46 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.